Connect with us

Hi, what are you looking for?

Friday, Jan 17, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.

Stock News

Oral drug and nutrient gel specialist soars after top client bumps up order by 50%

Gelteq Limited has a patented system used to improve absorption rates

Oral drug and nutrient delivery specialist soars after top client bumps up order by 50%
Gelteq's founders Nathan Gevoni (left) and Simon Szewach (right) got their IPO completed at the end of October. Photo credit: Gelteq Limited

Australia’s Gelteq Ltd (NASDAQ: GELS) was up by nearly 93 per cent on the Nasdaq Monday after its top American client upped its purchase order by 50 per cent. Gelteq specializes in oral drug and nutrient delivery using a proprietary system.

The customer, Health Extracts Inc (OTCMKTS: HYEX), is buying an unspecified quantity of Gelteq’s collagen and mynus sugar blocker gels. They are made to provide the consumer with the benefits of collagen protein while reducing sugar absorption in the body, potentially aiding with weight loss.

“Gelteq’s advanced technology offers a cutting-edge delivery system that empowers us to expand existing sales channels and capitalize on new market opportunities,” Health Extracts President, Duke Pitts, said in a statement.

Gelteq created its patented oral gel delivery method in partnership with Monash University in Melbourne. It is one of the world’s top institutions in the field of pharmaceutical science.

The school’s Monash Medicines Manufacturing Innovation Centre, backed by the Victorian State Government, has major customers like Pfizer Inc (NYSE: PFE) and Roche Holding AG (OTCMKTS: RHHBF)

Gelteq focuses on four key markets: sports nutrition, pharmaceuticals, pet health and nutraceuticals. Last week, the health and wellness operator announced that 400,000 of its gels were being produced for U.S. and Australian customers.

“Our patented technology can revolutionize the delivery of existing ingredients by integrating them into a gel, including, but not limited to: APIs, excipients, lipid-soluble, vitamins, minerals, proteins, carbohydrates and herbal extracts,” Gelteq explained.

Read more: Warehouse robotics specialist Symbotic drops 39% after accounting blunders

Read more: Japanese solar cell maker TOYO up 86% on major supply contract

Renowned fit chick advocates for gels

Gelteq is actively engaged in a partnership with Whitney Johns, a self-described “supplement snob.” She has over 1 million Instagram followers.

She uses Gelteq’s patented tech in her BRAIN ACTIVATE product — a cognitive enhancement supplement. It is part of the Whitney Johns Nutrition line.

“Not only are the gels easier to take than powders and pills, but also optimize absorption, delivering impressive results,” Johns said. “Partnering with Gelteq has truly set my supplement range apart, elevating it to new heights.”

She currently has a subscription-based app and fitness program called Fit With Whit. It provides customized workout and meal plans for users, functions as a fitness tracker and has a variety of mental health-oriented content.

Johns is also active on OnlyFans if you feel like paying for that.

Oral drug and nutrient delivery specialist soars after top client bumps up order by 50%

Whitney Johns, 2022. Photo credit: Sean Nelson via Facebook

 

Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Rowan Dunne on X

rowan@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cyber Security

BIO-key will provide the National Bank of Egypt with access to its PortalGuard identify management platform

Science and Research

The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis

Medical and Pharmaceutical

The stock rose by 146% in early morning trading on the Nasdaq

Medical and Pharmaceutical

The biopharma operator's 'HT-001" drug was highly successful in alleviating skin issues caused by a cancer treatment